Your browser doesn't support javascript.
loading
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population.
Patra, Tapas; Cunningham, David M; Meyer, Keith; Toth, Karoly; Ray, Ratna B; Heczey, Andras; Ray, Ranjit.
Affiliation
  • Patra T; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA. Electronic address: tpatra012@gmail.com.
  • Cunningham DM; Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Meyer K; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA.
  • Toth K; Department of Molecular Microbiology & Immunology and Saint Louis University, St. Louis, MO 63104, USA.
  • Ray RB; Department of Pathology, Saint Louis University, St. Louis, MO 63104, USA.
  • Heczey A; Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Ray R; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA; Department of Molecular Microbiology & Immunology and Saint Louis University, St. Louis, MO 63104, USA. Electronic address: rayr@slu.edu.
Mol Ther ; 31(3): 715-728, 2023 03 01.
Article in En | MEDLINE | ID: mdl-36609146
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Receptors, Chimeric Antigen / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Receptors, Chimeric Antigen / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2023 Type: Article